The value of mNGS in the diagnosis of central nervous system infections in immunodeficient hosts with decompensated cirrhosis complicated by Listeria encephalitis: Case Report - Scorecard - MDSpire
Advertisement
Utilizing mNGS for Diagnosing Central Nervous System Infections in Immunocompromised Patients with Decompensated Cirrhosis and Listeria Encephalitis: A Case Study
Clinical Scorecard: Utilizing mNGS for Diagnosing Central Nervous System Infections in Immunocompromised Patients with Decompensated Cirrhosis and Listeria Encephalitis: A Case Study
At a Glance
Category
Detail
Condition
Central Nervous System Infections
Key Mechanisms
Cirrhosis-associated immune dysfunction and Listeria monocytogenes infection
Target Population
Immunocompromised patients with decompensated cirrhosis
Care Setting
Clinical evaluation and management of CNS infections
Key Highlights
Increased incidence of CNS infections due to Listeria monocytogenes in immunocompromised patients.
mNGS provides rapid and accurate diagnosis, detecting pathogens within 16 hours.
Cirrhosis-associated immune dysfunction can mask typical CSF diagnostic markers.
Broad-spectrum antibiotics were initiated before culture results were available.
Early targeted therapy led to significant clinical improvement.
Guideline-Based Recommendations
Diagnosis
Utilize mNGS for rapid identification of pathogens in CNS infections.
Management
Initiate broad-spectrum antibiotics while awaiting culture results.
Monitoring & Follow-up
Regularly assess liver function and monitor for signs of infection.
Risks
Patients with decompensated cirrhosis are at increased risk for CNS infections.
Patient & Prescribing Data
Immunocompromised patients with decompensated cirrhosis.
Early mNGS-guided therapy can improve outcomes in CNS infections.
Clinical Best Practices
Consider mNGS for patients with atypical presentations of CNS infections.
Monitor for complications associated with cirrhosis in immunocompromised patients.
